PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME

Clinical trials for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME explained in plain language.

Never miss a new study

Get alerted when new PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME trials appear

Sign up with your email to follow new studies for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 2 Completed 1

New drug combo tested for Tough-to-Treat blood disorder

Disease control Completed

This small, early-stage study aimed to find a safe dose for combining two existing drugs, ibrutinib and lenalidomide, to treat myelodysplastic syndrome (MDS). It involved patients whose MDS had not responded to or who could not tolerate standard treatments. The main goal was to c…

Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME

Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME

Get alerted when new PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME trials appear

New drug combo tested for Tough-to-Treat blood disorder